These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2168536)

  • 21. N-fatty acyl compounds inhibit myristoyl acylation of pp60v-src and reduce tumorigenicity of Rous sarcoma virus-infected cells.
    Shoji S; Tsujita R; Hamuro T; Funakoshi T; Kubota Y
    Biochem Int; 1991 Jan; 23(1):15-23. PubMed ID: 1650555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rous sarcoma virus variants that encode src proteins with an altered carboxy terminus are defective for cellular transformation.
    Wilkerson VW; Bryant DL; Parsons JT
    J Virol; 1985 Aug; 55(2):314-21. PubMed ID: 2991557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pp60v-src tyrosine kinase is expressed and active in sarcoma-free avian embryos microinjected with Rous sarcoma virus.
    Howlett AR; Carter VC; Martin GS; Bissell MJ
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7587-91. PubMed ID: 2845414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.
    Catling AD; Fincham VJ; Frame MC; Haefner B; Wyke JA
    J Virol; 1994 Jul; 68(7):4392-9. PubMed ID: 8207813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of partially activated p60c-src in chicken embryo fibroblasts.
    Sato M; Kato J; Takeya T
    J Virol; 1989 Feb; 63(2):683-8. PubMed ID: 2463379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants.
    DeClue JE; Martin GS
    J Virol; 1989 Feb; 63(2):542-54. PubMed ID: 2536090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The v-Src and c-Src tyrosine kinases immunoprecipitated from Rous sarcoma virus-transformed cells display different peptide substrate specificities.
    Vojtechová M; Tuhácková Z; Hlavácek J; Velek J; Sovová V
    Arch Biochem Biophys; 2004 Jan; 421(2):277-82. PubMed ID: 14984208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
    Verderame MF; Kaplan JM; Varmus HE
    J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatidylinositol-3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts.
    Fukui Y; Saltiel AR; Hanafusa H
    Oncogene; 1991 Mar; 6(3):407-11. PubMed ID: 1849246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of YRP kinase by v-Src and protein kinase C-mediated signal transduction pathways.
    Scholz G; Felder MP; Hanafusa H
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2592-6. PubMed ID: 7535926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A glycoprotein in the plasma membrane matrix as a major potential substrate of p60v-src.
    Hamaguchi M; Matsuda M; Hanafusa H
    Mol Cell Biol; 1990 Feb; 10(2):830-6. PubMed ID: 2153925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src).
    Smart JE; Oppermann H; Czernilofsky AP; Purchio AF; Erikson RL; Bishop JM
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6013-7. PubMed ID: 6273838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation.
    Cross FR; Hanafusa H
    Cell; 1983 Sep; 34(2):597-607. PubMed ID: 6311433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of type I phosphatidylinositol kinase activity with mutationally activated forms of human pp60c-src.
    Chan TO; Tanaka A; Bjorge JD; Fujita DJ
    Mol Cell Biol; 1990 Jun; 10(6):3280-3. PubMed ID: 2160600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of tyrosine residues of calmodulin in Rous sarcoma virus-transformed cells.
    Fukami Y; Nakamura T; Nakayama A; Kanehisa T
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4190-3. PubMed ID: 2424020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ts Transformation mutants of avian sarcoma virus PRCII: lack of strict correlation between transforming ability and properties of the P105-associated kinase.
    Hirano A; Neil JC; Vogt PK
    Virology; 1983 Feb; 125(1):219-29. PubMed ID: 6187125
    [No Abstract]   [Full Text] [Related]  

  • 37. Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae.
    Florio M; Wilson LK; Trager JB; Thorner J; Martin GS
    Mol Biol Cell; 1994 Mar; 5(3):283-96. PubMed ID: 8049521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mutation in the catalytic domain of pp60v-src is responsible for the host- and temperature-dependent phenotype of the Rous sarcoma virus mutant tsLA33-1.
    Foster R; Martin GS
    Virology; 1992 Mar; 187(1):145-55. PubMed ID: 1310553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of c-Src activity by the expression of wild-type v-Src and its kinase-dead double Y416F-K295N mutant.
    Vojtechová M; Senigl F; Sloncová E; Tuhácková Z
    Arch Biochem Biophys; 2006 Nov; 455(2):136-43. PubMed ID: 17056000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of protein serine/threonine kinases p42, p63, and p87 in Rous sarcoma virus-transformed cells: signal transduction/transformation-dependent MBP kinases.
    Wang HC; Erikson RL
    Mol Biol Cell; 1992 Dec; 3(12):1329-37. PubMed ID: 1337288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.